2018
DOI: 10.1021/acsomega.8b01383
|View full text |Cite
|
Sign up to set email alerts
|

C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors

Abstract: Synthetic routes to potent bicyclic nonsteroidal sulfamate-based active-site-directed inhibitors of the enzyme steroid sulfatase (STS), an emerging target in the treatment of postmenopausal hormone-dependent diseases, including breast cancer, are described. Sulfamate analogs 9–27 and 28–46 of the core in vivo active two-ring coumarin template, modified at the 4- and 3-positions, respectively, were synthesized to expand structure–activity relationships. α-Alkylacetoacetates were used to synthesize coumarin sulf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 72 publications
0
16
0
Order By: Relevance
“…Hence, STS represents a central target for anti-cancer drug development. The STS inhibitor irosustat promisingly passed phase II clinical trials (5), and further drug development efforts are ongoing (194,195).…”
Section: Potential Applicationsmentioning
confidence: 99%
“…Hence, STS represents a central target for anti-cancer drug development. The STS inhibitor irosustat promisingly passed phase II clinical trials (5), and further drug development efforts are ongoing (194,195).…”
Section: Potential Applicationsmentioning
confidence: 99%
“…The synthesis of sulphamoylated coumarin derivatives is still one of the main directions in the development of compounds with STS inhibitory activities. Ganeshapillai et al 59 synthesised a series of novel STS inhibitors based on bicyclic coumarin sulphamates. Based on the chemical structure of COUMATE, a large library of C-3-and C-4-substituted derivatives containing a sulphamate moiety was obtained and a wide SAR analysis was performed.…”
Section: Nonsteroidal Sts Inhibitors Containing a Sulphamate Moietymentioning
confidence: 99%
“…Thus, inhibition of STS represents an attractive avenue for treatment of those hormone-dependent cancers [1,2]. Numerous molecules possessing the unsubstituted sulfamate moiety have been reported and developed as STS inhibitors [3][4][5][6][7][8][9][10][11][12][13][14][15][16]. An aryl sulfamate moiety is essential for potent inhibition [3,5].…”
Section: Introductionmentioning
confidence: 99%